Candidate risk factors for cardiovascular disease in CKD

Seminars in Nephrology

Volumn 26, Issue 1, 2006, Pages 1-2

  De Santo, Natale G ^a   Cirillo, Massimo ^a   Perna, Alessandra ^a   Iacono, Giovanni ^a   Capasso, Giovambattista ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PARATHYROID HORMONE; PYRIDOXINE; RIBOFLAVIN;

ARTERY CALCIFICATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DEPRESSION; DIALYSIS; EDITORIAL; ERECTILE DYSFUNCTION; GENE EXPRESSION; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; METHYLATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SLEEP DISORDER; STROKE; UREMIA;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; RISK FACTORS;

EID: 30444431587     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2005.06.001     Document Type: Editorial

References (18)

1. M.E. Suliman, H. Kalantar-Zade, B. Lindholm Homocysteine in uraemia - a puzzling and conflicting story Nephrol Dial Transplant 20 2005 16 21
2. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke JAMA 288 2002 2015 2022
3. J.P. Casas, L.E. Bautista, L. Smeeth Homocysteine and stroke Evidence on a causal link from mendelian randomisation Lancet 365 2005 224 232
4. A.F. Perna, D. Ingrosso, E. Satta Homocysteine metabolism in renal failure Curr Opin Clin Nutr Metab Care 7 2004 53 57
5. A.F. Perna, F. Acanfora, E. Satta Hyperhomocysteinemia and cardiovascular disease in uremia The newest evidence in epidemiology and mechanisms of action Semin Nephrol 24 2004 426 430
6. D. Ingrosso, A. Cimmino, A.F. Perna Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia Lancet 361 2003 1693 1699
7. A.G. Bostom, J. Selhub, P.F. Jacques Power shortage Clinical trials testing the homocysteine hypothesis against a background of folic acid-fortified cereal grain flour Ann Intern Med 135 2001 133 137
8. National Kidney Foundation K/DOQI clinical guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 43 suppl 3 2003 S1 S201
9. M. Cozzolino, M. Gallieni, D. Brancaccio Vascular calcification in uremic conditions New insights into pathogenesis Semin Nephrol 26 2006 33 37
10. S.G. Massry, M. Smorgorzewski Management of vascular calcification in CKD patients Semin Nephrol 26 2006 38 41
11. J.A. Gillaspy, S. Hansen Tenth international conference on psychonephrology Dial Transpl 26 1997 552 553
12. BURC: Bulletin of Regione Campania, Regione Campania, Naples, August 31, 2004
13. M. Fabrazzo, R.M. De Santo Depression in chronic kidney disease Semin Nephrol 26 2006 56 60
14. G. Bellinghieri, V. Savica, D. Santoro Vascular erectile dysfunction in chronic renal failure Semin Nephrol 26 2006 42 45
15. P.L. Kimmel, S.S. Patel Quality of life in patients with chronic kidney disease Focus on end-stage renal disease treated with hemodialysis Semin Nephrol 26 2006 68 79
16. R.M. De Santo, F. Lucidi, C. Violani Sleep disorders in hemodialyzed patients The role for comorbidities Int J Artif Organs 28 2005 670 677
17. C. Violani, F. Lucidi, C. Lombardo Insomnia and comorbidities in chronic kidney disease Semin Nephrol 26 2006 61 63
18. R.M. De Santo, M.N. Bartiromo, M.C. Cesare Sleeping disorders in early chronic kidney disease Semin Nephrol 26 2006 64 67